| Title | Name | Date | Time | Session type |
| Handling Uncertainty in Health Technology Assessment Process | Lotte Steuten | 05 May 2024 | 13:00 – 17:00 EDT | Short Course |
| A Targeted Literature Review to Identify the Dimensions of Sustainable Global Biosimilars Markets | Mireia Jofre-Bonet | 06 May 2024 | 10:30 EDT | Poster Session |
| Value Assessment and Reimbursement of Early Treatment for Prevention in Chronic Progressive Diseases: Are Traditional Approaches Up to the Task? | Amanda Cole | 07 May 2024 | 13:45 – 14:45 EDT | Panel Discussion |
| Are proposals for a scheme to stimulate investment in critically needed new antimicrobials fit for purpose? | Grace Hampson & Matthias Hofer | 07 May 2024 | 13:45 – 14:45 EDT | Podium Session |
| How elastic is biopharmaceutical innovation with respect to expected reward? What is missing from existing literature on elasticity of innovation? | Amanda Cole | 07 May 2024 | 17:00 – 18:00 EDT | Panel Discussion |
| How Can Grace and Other Novel Methods Estimate ISPOR Value Flower Components? A User Guide to Generalized Cost Effectiveness Analysis (GCEA) | Lotte Steuten | 08 May 2024 | 08:00-09:00 EDT | Panel Discussion |
POST PICKER (PEOPLE)